期刊名称：CLINICAL ENDOCRINOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Clinical Endocrinology publishes papers and reviews which focus on the clinical aspects of endocrinology, including the clinical application of molecular endocrinology. It features reviews, original papers, commentaries, cases of the month, book reviews and letters to the editor. Clinical Endocrinology is essential reading not only for those engaged in endocrinological research but also for those involved primarily in clinical practice
Instructions to Authors
Clinical Endocrinology encourages the online submission of your manuscripts. Authors should in the first instance submit their manuscripts through http://cen.manuscriptcentral.com. Support for online submission is available at http://blackwellsupport.custhelp.com or by e-mail to manuscriptcentral@oxon.blackwellpublishing.co.uk. Telephone support is available in the USA (+1 434-817-2040 ext 167). If online submission is not possible, authors from Europe (except UK), the Americas and Australasia/Japan/South-East Asia should send original papers to the appropriate regional editor.
European authors may alternatively send their original papers to the Oxford address (with a disk).
Australasia/Japan/SouthEast Asia
P. Fuller
Prince Henry's Institute of Medical Research
Monash Medical Centre
PO Box 5152
Clayton
Victoria 3168
Australia
Tel: + 61 3 9550 4372
Fax: + 61 3 9550 6125
e-mail: claudette.thiedeman@med.monash.edu.au
Americas
J. Fagin
Clinical Endocrinology
3125 Eden Avenue
Room 1327 Vontz
Cincinnati, OH 45267-0547
USA
Tel: + 1 513 558 4444
Fax: + 1 513 558 8581
e-mail: wilsjm@ucmail.uc.edu
Europe
P.A. Colao
Department of Molecular and Clinical Endocrinology and Oncology
'Federico II' University of Naples
Via Sergio Pansini 5
80131-Naples
Italy
Tel: + 39 081 7462132
Fax: + 39 081 7463668
e-mail: colao@unina.it
All other manuscripts, including Reviews and Case Reports, should be sent to:
The Editors
Clinical Endocrinology
9600 Garsington Road
OX2 2DQ
E-mail: faye.cheeseman@blacksci.co.uk
Fax: + 44 (0)1865 471320
Overseas authors submitting to the UK office are encouraged to do so by e-mail (faye.cheeseman@oxon.blackwellpublishing.com) or facsimile (+44 (0)1865 471320).
When the final revision of the paper is submitted, please send this on disk as well as typescript. The final version of the hard copy and the file on the disk must be the same. Note the software used, the type of computer and any special (non-keyboard) characters used.
Papers are accepted on the understanding that no substantial part has been, or will be, published elsewhere. Papers may be subject to editorial revision without notice and remain the copyright of the journal. If a paper returned to authors for revision is not received back in the editorial office after 90 days, it will be treated as a new submission. The Editors reserve the right to make the final decision whether or not a paper is accepted.
Authors must indicate in the text the way in which they have complied with the recommendations of the Declaration of Helsinki (British Medical Journal, 1964, ii, 177). Normally, experimental human studies should first have been approved by a local Ethical Committee, and a statement to this effect should be included.
An Author's Declaration and Copyright form, obtained from the Journal or the office of Clinical Endocrinology, must accompany each paper submitted and should be signed by all authors. A completed copyright assignment form must be included with the submitted manuscript.
Manuscripts must be typewritten (double-spaced) on one side of the paper only. The text must be preceded by a structured summary to include the following headings: objective, including a background sentence setting the study in context, design, patients, measurements, results, conclusions.
Only those abbreviations listed below may be used in the summary. A single 'front page' must give: (1) the title; (2) a short title; (3) the name(s) of the author(s); (4) the department(s) in which the work was done; and (5) the name, full postal address, fax number and e-mail address of the author to whom the proofs and requests for offprints should be sent, to be headed 'Correspondence'; (6) a list of no more than five keywords related to subjects discussed in the paper.
Papers must be written in clear, concise English. Spelling should follow The Concise Oxford Dictionary of Current English (Clarendon Press, Oxford) Avoid jargon and neologisms. The journal is not prepared to undertake major corrections of language, which is the responsibility of the author. Where English is not the first language of the authors, the paper must be checked by a native English speaker. Authors may suggest the names of suitable referees if they wish.
Rapid Communications
Rapid communications should consist of new data of sufficient importance to warrant immediate publication. The submitted paper should be self-contained and not a tentative preliminary communication. It will be refereed very quickly and any revision must be dealt with promptly.
It is expected that the time interval between the acceptance and subsequent publication of the manuscript will be approximately 3 months. If the Editors consider the article unsuitable for publication as a rapid communication it will be processed as a normal paper unless it is withdrawn by the authors.
Correspondence
Correspondence will be considered for publication if it contains constructive criticism on published articles, the authors of which will be given the right of reply. Items of topical interest, including case reports presenting a significant advance in therapy or highlighting substantial scientific advances in understanding the mechanism(s) of the disease process, will also be considered under this heading.
Review Articles
Review articles are normally commissioned, but we also welcome suggestions for Review titles and authors. Anyone wishing to write a review for the journal should first contact the Reviews Editors (j.a.franklyn@bham.ac.uk; p.m.stewart@bham.ac.uk).
Figures and Tables
Figures requiring halftone illustration should be well-contrasted prints, on glossy paper, and each should be labelled on the back with the names(s) of author(s), figure number and the 'Top edge' identification. A separate sheet, containing the legends of the figures, must be included. If colour figures are requested, the author(s) must bear the extra cost of reproduction. Colour figures must be submitted as glossy originals or transparencies. . Digital artwork files for reproduction should preferably be EPS or TIFF and meet our standards, but we may be able to use other formats so please include these (see www.blackwell-science.com/elecmed/digill.htm or e-mail artwork@blacksci.co.uk). Figures should be included with online submissions, either as JPEG, GIF, TIFF, BMP, PICT with RTF manuscripts or embedded in the PDF file.
Tables should be typed on separate sheets, numbered (with arabic numbers) and have a title. The position of figures and tables should be indicated in the margin of the manuscript. Save figures on disks in as many different formats as are available to you. Colour reproductions will incur a charge.
Colour
It is the policy of CEN for authors to pay the full cost for the reproduction of their colour artwork.
Therefore, please note that if there is colour artwork in your manuscript when it is accepted for publication, Blackwell Publishing require you to complete and return a colour work agreement form before your paper can be published. This form can be downloaded as a PDF* from the internet. The web address for the form is: http://www.blackwellpublishing.com/pdf/Sub3000_X_CoW.pdf
If you are unable to access the internet, or are unable to download the form, please contact the Production Editor at:
Vicky.taylor@oxon.blackwellpublishing.com
And they will be able to email or FAX a form to you.
Once completed, please return the form to the Production Editor at the address below:
Vicky Taylor
Blackwell Publishing Ltd
9600 Garsington Road
Oxford OX4 2DQ, UK
Fax: +44 (0) 1865 471470
Any article received by Blackwell Publishing with colour work will not be published until the form has been returned.
* To read PDF files, you must have Acrobat Reader installed on your computer. If you do not have this program, this is available as a free download from the following web address: http://www.adobe.com/products/acrobat/readstep2.html
Statistics
Special attention must be paid to the appropriate use of statistical methods in both the design and analysis of the study. Authors are advised to consider the recommendations published in the British Medical Journal (1983) 286, 1489-1493. Manuscripts may be reviewed by the journal's medical statistician.
Units
SI units but not mass units should be used throughout. Pituitary and other hormones expressed in units per litre should quote the appropriate standard reference preparation used in the assay. If GH is expressed in mass units, a conversion factor must be given.
Abbreviations
In general the Journal follows the recommendations in Units, Symbols and Abbreviations (1988). Royal Society of Medicine, London.
The following abbreviations may be used without definition:
ACTH corticotrophin; ADH antidiuretic hormone, vasopressin; AVP arginine vasopressin; FSH follicle stimulating hormone; GH growth hormone; GnRH gonadotrophin releasing hormone; hCG human chorionic gonadotrophin; hMG human menopausal gonadotrophin: hPL human placental lactogen; IGF insulin-like growth factor: IGFBP insulin like growth factor binding protein; LH luteinizing hormone; OT oxytocin; PRL prolactin; PTH parathyroid hormone; SHBG sex hormone binding globulin; T4 thyroxine; T3 triiodothyronine; rT3 reverse T3: TRH thyrotrophin releasing hormone; TSH thyrotrophin: VIP vasoactive intestinal peptide.
The Biochemical Journal (1975) 145, 1011, enumerates abbreviations for certain compounds (such as ATP, DNA. DEA E-cellulose, etc.) and also describes the correct use of chemical names and formulae.
All other abbreviations must be defined where they are introduced.
Chemical symbols and formulae should not be used in the text.
Steroids
Authors should follow the recommendations for steroid nomenclature published in the Journal of Endocrinology (1980) 84, 3-4.
Amino Acids
Abbreviations may only be used in tables and for representing polymers or sequences in the text [see Biochemical Journal (1975) 145, 11]. Isotopically Labelled Compounds
See Biochemical Journal (1975) 145,13-14 and the Radiochemical Catalogue (Radiochemical Centre, Amersham, Bucks).
Solutions
Solutions should be described in terms of molarity (M), not normality (N). For values less than 0.1 M use mM (50 mM not 0.05 M). Buffers: composition, pH and method of adjustment should be given, e.g. 0.1 M potassium dihydrogen phosphate adjusted to pH 7.4 with 2 M sodium hydroxide. Volume ratios - e.g. methanol: water, 8 2 v/v (use 'by vol.' instead of v/v if more than two substances are involved).
Time
Editorial Board
Senior Editors
P. M. Stewart, Queen Elizabeth Hospital, Birmingham, UK
J. A. Franklyn, Queen Elizabeth Hospital, Birmingham, UK
Editors
P.A. Colao (Europe), Department of Molecular and Clinical Endocrinology and Oncology, 'Federico II' University of Naples, Via Sergio Pansini 5, 80131-Naples, Italy
J. Fagin (Americas), Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, 231 Bethesda Ave, Cincinnati, OH45267-0001, USA
P. Fuller (Australasia/Japan/South-East Asia) Prince Henry's Institute of Medical Research, Monash Medical Centre, PO Box 5152, Clayton, Victoria 3168, Australia
Associate Editors
J.S. Bevan, Aberdeen Royal Infirmary, Aberdeen, UK
J. Newell-Price, Northern General Hospital, Sheffield, UK
J. Webster, Northern General Hospital, Sheffield, UK
Medical Statisticians
R. Holder, University of Birmingham, Birmingham, UK
M. Kenward, London School of Hygiene and Tropical Medicine, London, UK
Editorial Board
L. Rees (Chairman) St Bartholomew's Hospital, London
R. Auchus University of Texas Southwestern Medical School,
Dallas
P. Chanson Centre Hospitalier Universitaire de Bic¨ºtre, Paris
J.S. Christiansen 2nd University Clinic of Internal Medicine,
Denmark
J.M.C. Connell Western Infirmary, Edinburgh
G.S. Conway The Middlesex Hospital, London
J. D'Ercole University of North Carolina, North Carolina
R. Eastell Northern General Hospital, Sheffield
J. Gregory University of Wales, Cardiff
A.B. Grossman St Bartholomew's Hospital, London
P. Jenkins St Bartholomew's Hospital, London
S. Judd Flinders Medical Centre, Australia
H. Jueppner Massachusetts General Hospital, Boston
P. Kendall-Taylor University of Newcastle,
Newcastle-Upon-Tyne
P. Laurberg Aalberg Hospital, Denmark
F. Mantero University of Padua, Italy
B. Mendonca University of Sao Paulo, Brazil
A.M. McNicol Glasgow Royal Infirmary, Glasgow
S. Pearce University of Newcastle, Newcastle-Upon-Tyne
P. Perros The Freeman Hospital, Newcastle
H.A.P. Pols University Hospital Dijkzigt, Netherlands
M. Samuels Oregon Health Sciences University, Portland
C. Stratakis National Institute of Child Health & Human
Development, Maryland
S. Taheri The Hammersmith Hospital, London
A.J. Van der Lely University Hospital Dijkzigt, The
Netherlands
M. Walker University of Newcastle upon Tyne, Newcastle
upon Tyne
W.M. Wiersinga University of Amsterdam, The Netherlands
G. Williams Hammersmith Hospital, London
| 
